Professional Documents
Culture Documents
Carotid Artery Disease and Management
Carotid Artery Disease and Management
Naylor R et al., European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic
Carotid and Vertebral Artery Disease, European Journal of Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2022.04.011
Definitions
Causes
Asymptomatic CEA
>50% Stenosis
For these patient councelling is recommended to improve diet, stop smoking best DM
control, BP, DM
Also Low dose aspirin 75mg= prevents death from Mis as most have underlying CAD
If intolerant to aspirin then low dose CLOPIDOGREL, If intolerant then dipyridamole 200mg
If are due to have CAS (Carotid artery stenting) then Dual AP is needed before surgery –
Aspirin + Clopidogrel
Treatment
Symptomatic group
>=70% Stenosis = CEA +BMT (Level1 evidence)
>60-69% Stenosis = again CEA +BMT (But level 2 evidence)
>50% + those with near occlusion need BMT first and if recurrence stroke then they can be
considered for CEA+BMT OR CAS+BMT
Asymptomatic
>60% If high risk findings . >5 year prognosis then CEA +BMT If not BMT
Oclussion or near occlusion or <60% stenosis = BMT Level 1
Procedure related complications and Mx
For patients who develop an ipsilateral neurological deficit after flow is restored following
carotid clamp release when carotid endarterectomy is performed under locoregional
anaesthesia, immediate re-exploration of the carotid artery is recommended.
Following CEA Pt can develop a haemaotoma which can compromise the airway and a
prophylactic wound dressing is recommended
Symptomatic Re-stenosis
>50%= re-do CEA
<50% = BMT